These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 30606137

  • 1. A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
    Alibhai SMH, Santa Mina D, Ritvo P, Tomlinson G, Sabiston C, Krahn M, Durbano S, Matthew A, Warde P, O'Neill M, Timilshina N, Segal R, Culos-Reed N.
    BMC Cancer; 2019 Jan 03; 19(1):2. PubMed ID: 30606137
    [Abstract] [Full Text] [Related]

  • 2. A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
    Alibhai SM, Santa Mina D, Ritvo P, Sabiston C, Krahn M, Tomlinson G, Matthew A, Segal R, Warde P, Durbano S, O'Neill M, Culos-Reed N.
    BMC Cancer; 2015 Apr 25; 15():312. PubMed ID: 25908311
    [Abstract] [Full Text] [Related]

  • 3. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
    Alibhai SMH, Ritvo P, Santa Mina D, Sabiston C, Krahn M, Tomlinson G, Matthew A, Lukka H, Warde P, Durbano S, O'Neill M, Culos-Reed SN.
    BMC Cancer; 2018 Oct 23; 18(1):1031. PubMed ID: 30352568
    [Abstract] [Full Text] [Related]

  • 4. Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis.
    Alibhai SMH, Papadopoulos E, Mina DS, Ritvo P, Tomlinson G, Sabiston CM, Durbano S, Bremner KE, Chiarotto J, Matthew A, Warde P, O'Neill M, Culos-Reed SN.
    J Geriatr Oncol; 2024 Jan 23; 15(1):101646. PubMed ID: 37976654
    [Abstract] [Full Text] [Related]

  • 5. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P, Galvão DA, Spry N, Joseph D, Chee R, Taaffe DR, Chambers SK, Newton RU.
    BJU Int; 2015 Feb 23; 115(2):256-66. PubMed ID: 24467669
    [Abstract] [Full Text] [Related]

  • 6. Group-based exercise in daily clinical practice to improve physical fitness in men with prostate cancer undergoing androgen deprivation therapy: study protocol.
    Østergren P, Ragle AM, Jakobsen H, Klausen TW, Vinther A, Sønksen J.
    BMJ Open; 2016 Jun 29; 6(6):e011460. PubMed ID: 27357198
    [Abstract] [Full Text] [Related]

  • 7. Preference-based versus randomized controlled trial in prostate cancer survivors: Comparison of recruitment, adherence, attrition, and clinical outcomes.
    Alibhai SMH, Papadopoulos E, Durbano S, Tomlinson G, Mina DS, Ritvo P, Sabiston CM, Matthew AG, Chiarotto J, Sidani S, Culos-Reed SN.
    Front Oncol; 2022 Jun 29; 12():1033229. PubMed ID: 36578945
    [Abstract] [Full Text] [Related]

  • 8. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
    Murphy K, Kehoe B, Denieffe S, Hacking D, Fairman CM, Harrison M.
    Contemp Clin Trials; 2024 Jan 29; 136():107388. PubMed ID: 37972755
    [Abstract] [Full Text] [Related]

  • 9. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
    Dawson JK, Dorff TB, Todd Schroeder E, Lane CJ, Gross ME, Dieli-Conwright CM.
    BMC Cancer; 2018 Apr 03; 18(1):368. PubMed ID: 29614993
    [Abstract] [Full Text] [Related]

  • 10. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
    Thorsen L, Nilsen TS, Raastad T, Courneya KS, Skovlund E, Fosså SD.
    BMC Cancer; 2012 Mar 29; 12():123. PubMed ID: 22458865
    [Abstract] [Full Text] [Related]

  • 11. Effects of recreational soccer in men with prostate cancer undergoing androgen deprivation therapy: study protocol for the 'FC Prostate' randomized controlled trial.
    Uth J, Schmidt JF, Christensen JF, Hornstrup T, Andersen LJ, Hansen PR, Christensen KB, Andersen LL, Helge EW, Brasso K, Rørth M, Krustrup P, Midtgaard J.
    BMC Cancer; 2013 Dec 13; 13():595. PubMed ID: 24330570
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial.
    Uth J, Hornstrup T, Christensen JF, Christensen KB, Jørgensen NR, Schmidt JF, Brasso K, Jakobsen MD, Sundstrup E, Andersen LL, Rørth M, Midtgaard J, Krustrup P, Helge EW.
    Osteoporos Int; 2016 Apr 13; 27(4):1507-1518. PubMed ID: 26572756
    [Abstract] [Full Text] [Related]

  • 13. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE, Leslie WD, Lau YK.
    BMC Cancer; 2012 Mar 21; 12():103. PubMed ID: 22436542
    [Abstract] [Full Text] [Related]

  • 14. Erratum.
    Mult Scler; 2016 Oct 21; 22(12):NP9-NP11. PubMed ID: 26041800
    [Abstract] [Full Text] [Related]

  • 15. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
    Galvão DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, Lamb DS, Chambers SK, Newton RU.
    Eur Urol; 2014 May 21; 65(5):856-64. PubMed ID: 24113319
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND).
    Harrison MR, Davis PG, Khouri MG, Bartlett DB, Gupta RT, Armstrong AJ, McNamara MA, Zhang T, Anand M, Onyenwoke K, Edwardson S, Craig D, Michalski M, Wu Y, Oyekunle T, Coyne B, Coburn A, Jones LW, George DJ.
    Prostate Cancer Prostatic Dis; 2022 Mar 21; 25(1):58-64. PubMed ID: 35273377
    [Abstract] [Full Text] [Related]

  • 17. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review.
    Gardner JR, Livingston PM, Fraser SF.
    J Clin Oncol; 2014 Feb 01; 32(4):335-46. PubMed ID: 24344218
    [Abstract] [Full Text] [Related]

  • 18. Improving bone health in men with prostate cancer receiving androgen deprivation therapy: Results of a randomized phase 2 trial.
    Alibhai SMH, Breunis H, Timilshina N, Hamidi MS, Cheung AM, Tomlinson GA, Manokumar T, Samadi O, Sandoval J, Durbano S, Warde P, Jones JM.
    Cancer; 2018 Mar 15; 124(6):1132-1140. PubMed ID: 29211305
    [Abstract] [Full Text] [Related]

  • 19. Protocol for GET FIT Prostate: a randomized, controlled trial of group exercise training for fall prevention and functional improvements during and after treatment for prostate cancer.
    Winters-Stone KM, Li F, Horak F, Dieckmann N, Hung A, Amling C, Beer TM.
    Trials; 2021 Nov 06; 22(1):775. PubMed ID: 34742325
    [Abstract] [Full Text] [Related]

  • 20. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR, Buffart LM, Newton RU, Spry N, Denham J, Joseph D, Lamb D, Chambers SK, Galvão DA.
    BJU Int; 2018 Feb 06; 121(2):194-202. PubMed ID: 28872752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.